By: Deshotel, Delisi, Bonnen, H.B. No. 1379
      Howard of Travis, et al.
 
 
A BILL TO BE ENTITLED
 
AN ACT
  relating to human papillomavirus education programs.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  Subchapter A, Chapter 161, Health and Safety
  Code, is amended by adding Section 161.0107 to read as follows:
         Sec. 161.0107.  HUMAN PAPILLOMAVIRUS; VACCINES EDUCATION
  MATERIALS.  The department, using existing resources, shall produce
  and distribute informational materials regarding vaccines against
  human papillomavirus that are approved by the United States Food
  and Drug Administration for human use. The materials must include
  information relating to the effectiveness, availability, and
  contraindications of the vaccines. The materials must be available
  in English and in Spanish.
         SECTION 2.  Chapter 163, Health and Safety Code, is amended
  by adding Section 163.003 to read as follows:
         Sec. 163.003.  ADDITIONAL INSTRUCTIONAL ELEMENTS REGARDING
  HUMAN PAPILLOMAVIRUS.  Course materials and instruction relating to
  sexually transmitted diseases must be available in English and in
  Spanish and should include:
               (1)  the following specific information on human
  papillomavirus:
                     (A)  that sexual intercourse is not required to
  become infected with human papillomavirus and that the avoidance of
  skin-to-skin contact involving the genital areas offers the best
  protection;
                     (B)  that both males and females may be infected
  with human papillomavirus and symptoms may not be present;
                     (C)  that younger women are at greater risk of
  human papillomavirus infection than older women; and
                     (D)  that human papillomavirus may be transmitted
  to an infant during childbirth;
               (2)  information regarding the role of human
  papillomavirus in the development of genital warts, cervical
  cancer, and other diseases; and
               (3)  information regarding the continuing need for
  women to undergo Pap smear testing, even if they have received a
  vaccination against human papillomavirus.
         SECTION 3.  This Act takes effect September 1, 2007.